Tu Yan, Johnstone Cameron N, Stewart Alastair G
Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, Melbourne, Australia.
Cancer & Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Australia.
Pharmacol Res. 2017 May;119:278-288. doi: 10.1016/j.phrs.2017.02.011. Epub 2017 Feb 14.
Annexin A1 is a multifunctional protein characterised by its actions in modulating the innate and adaptive immune response. Accumulating evidence of altered annexin A1 expression in many human tumours raises interest in its functional role in cancer biology. In breast cancer, altered annexin A1 expression levels suggest a potential influence on tumorigenic and metastatic processes. However, reports of conflicting results reveal a relationship that is much more complex than first conceptualised. In this review, we explore the diverse actions of annexin A1 on breast tumour cells and various host cell types, including stromal immune and structural cells, particularly in the context of cancer immunoediting.
膜联蛋白A1是一种多功能蛋白,其作用特点是调节先天性和适应性免疫反应。越来越多的证据表明,膜联蛋白A1在许多人类肿瘤中的表达发生改变,这引发了人们对其在癌症生物学中功能作用的兴趣。在乳腺癌中,膜联蛋白A1表达水平的改变表明其对肿瘤发生和转移过程可能有影响。然而,相互矛盾的结果报告显示,这种关系比最初设想的要复杂得多。在本综述中,我们探讨了膜联蛋白A1对乳腺肿瘤细胞和各种宿主细胞类型(包括基质免疫细胞和结构细胞)的多种作用,特别是在癌症免疫编辑的背景下。